Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 615 N Wolfe St., Baltimore, Maryland, 21205, USA.
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 615 N Wolfe St., Baltimore, Maryland, 21205, USA; Department of Health Policy and Management, UCLA Fielding School of Public Health, 650 Charles E. Young Dr. S., Los Angeles, CA 90095, USA.
Drug Alcohol Depend. 2020 Nov 1;216:108321. doi: 10.1016/j.drugalcdep.2020.108321. Epub 2020 Sep 25.
With the emergence of illicit fentanyl, fentanyl-involved overdose rates increased from 2013 to 2017 in the United States (US). We describe US trends in opioid-related overdose mortality rates by race, age, urbanicity, and opioid type before and after the emergence of fentanyl.
Using the Centers for Disease Control and Prevention's WONDER database, we estimated crude and age-standardized opioid-related overdose mortality rates at the intersections of race (non-Hispanic [NH] Black and white), age (<55 and ≥55 years), sex (male and female) and urbanicity (urban and rural residence) from 2005 to 2017. We compare relative changes in mortality from 2013 to 17, and describe changes in the contributions of fentanyl, heroin, and other opioids to opioid-related overdose mortality.
From 2013 to 2017, the overall opioid overdose mortality rate was consistently higher in NH white Americans, however, the rate increase was greater among NH Black (174 %) compared to NH white (85 %) Americans. The steepest increases occurred in the overdose rates between 2013 and 2017 among younger (aged <55 years) urban NH Black Americans (178 % increase). Among older (≥55 years) adults, only urban NH Black Americans had an increase in overdose-related mortality rate (87 % increase). Urban NH Black Americans also experienced the greatest increase in the percent of fentanyl-involved deaths (65 % in younger, 61 % in older).
In the era of increased availability of illicitly manufactured fentanyl (2013-2017), there has been a disproportionate increase in opioid-related overdose deaths among urban NH Black Americans. Interventions for urban NH Black Americans are urgently needed to halt the increase in overdose deaths.
随着非法芬太尼的出现,美国(美国)2013 年至 2017 年芬太尼涉及的过量用药率有所上升。在芬太尼出现之前和之后,我们描述了美国按种族、年龄、城市和阿片类药物类型划分的与阿片类药物相关的过量死亡率趋势。
使用疾病控制与预防中心的 WONDER 数据库,我们从 2005 年至 2017 年,在种族(非西班牙裔[NH]黑人和白人)、年龄(<55 岁和≥55 岁)、性别(男性和女性)和城市(城市和农村居民)的交叉点上估计了粗死亡率和年龄标准化的与阿片类药物相关的过量死亡率。我们比较了 2013 年至 17 年的死亡率相对变化,并描述了芬太尼、海洛因和其他阿片类药物对与阿片类药物相关的过量死亡率的贡献变化。
从 2013 年到 2017 年,NH 白种美国人的总体阿片类药物过量死亡率一直较高,但 NH 黑种美国人(174%)的增长率高于 NH 白种美国人(85%)。在 2013 年至 2017 年期间,年轻(<55 岁)城市 NH 黑种美国人(178%)的阿片类药物过量率急剧上升。在年龄较大(≥55 岁)的成年人中,只有城市 NH 黑种美国人的与阿片类药物相关的死亡率有所增加(增加 87%)。城市 NH 黑种美国人也经历了芬太尼参与死亡人数的百分比(年轻组为 65%,年长组为 61%)的最大增长。
在非法制造的芬太尼(2013-2017 年)供应增加的时代,城市 NH 黑种美国人与阿片类药物相关的过量死亡人数不成比例地增加。迫切需要针对城市 NH 黑种美国人采取干预措施,以阻止过量死亡人数的增加。